Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MaryAnn Wilbur"'
Autor:
Julia Schlossman, Michelle Vu, Alexandra Samborski, Karolina Breit, Kelly Thevenet-Morrison, MaryAnn Wilbur
Publikováno v:
Gynecologic Oncology Reports, Vol 49, Iss , Pp 101267- (2023)
Objective: To (1) identify the major barriers premenopausal individuals face in accessing fertility care at the time of gynecologic cancer diagnosis and (2) to assess patient experiences pertaining to fertility. Methods: We distributed an online surv
Externí odkaz:
https://doaj.org/article/597f24b87a5c48378986734579198915
Autor:
Alexandra Morell, Alexandra Samborski, Devin Williams, Elizabeth Anderson, Julie Kittel, Kelly Thevenet-Morrison, MaryAnn Wilbur
Publikováno v:
Gynecologic Oncology. 172:115-120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::268f208e8807a026f4b97bc4f6e47735
https://doi.org/10.1016/j.ygyno.2023.03.015
https://doi.org/10.1016/j.ygyno.2023.03.015
Autor:
MaryAnn, Wilbur
Publikováno v:
New England Journal of Medicine. 385:2309-2311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9eddb65ea841024e66037a1d70e58ed
https://doi.org/10.1056/nejmp2110161
https://doi.org/10.1056/nejmp2110161
Publikováno v:
Journal of Clinical Oncology. 40:287-287
287 Background: Individuals who have received treatment for gynecologic malignancy often have reduced fertility options. However, there is a paucity of data on patient experience about this aspect of their treatment. The primary objective of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e590c9b74f4a1e63b09b9aee2a06b1b
https://doi.org/10.1200/jco.2022.40.28_suppl.287
https://doi.org/10.1200/jco.2022.40.28_suppl.287
Autor:
Alexandra Samborski, MaryAnn Wilbur, Lila Marshall, Lauren Mahon, Elizabeth Anderson, Kelly Thevenet-Morrison, Meghan Underhill-Blazey
Publikováno v:
Journal of Clinical Oncology. 40:e17607-e17607
e17607 Background: All patients with a diagnosis of epithelial ovarian, tubal or peritoneal cancer should receive genetic counseling and be offered germline testing, based on the Society for Gynecologic Oncology 2014 position statement. This informat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c16c0b4e6e241a8de4c1f8b8bd236d94
https://doi.org/10.1200/jco.2022.40.16_suppl.e17607
https://doi.org/10.1200/jco.2022.40.16_suppl.e17607